Artificial Hip Joint Market, By Type (Metal-on-Metal, Metal-on-Polyethylene, Ceramic-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Artificial Hip Joint Market was valued at US$ 6.7 billion in 2024 and is projected to grow at a CAGR of 5.3% to reach US$ 10.7 billion by 2034.

An artificial hip joint, also known as a hip replacement, is a medical device used to replace a damaged or diseased hip joint. It is a highly successful surgery that can significantly improve quality of life for people with severe hip pain and limitations. Hip replacement surgery is a major procedure, but it is generally very safe and effective. Most people who have hip replacement surgery experience significant pain relief and improved mobility significantly enhancing one's quality of life. Following hip replacement surgery, many patients report being able to engage in activities that they were not able to perform prior to the procedure.There are two main types of hip replacement surgery which are responsible for driving the Artificial Hip Joint Market. Total hip replacement (THR) in which both the socket and the ball of the hip joint are replaced with artificial hip joint components. Secondly there is partial hip replacement in which, only the ball of the hip joint is replaced with an artificial component. The socket is left intact.

The growing geriatric population (especially elderly with active lifestyles) worldwide as well as rising life expectancy due to rapid medical advances are major drivers of the Artificial Hip Joint Market. Minimally invasive surgery, improved implant design (durability, biocompatibility, and customization), robotics, 3D printing and other technological advances have increased the success rates of such complex surgeries while significantly reducing patient recovery time. This has prompted worldwide acceptance and rapid adoption of hip replacement surgeries prompting further growth in Artificial Hip Joint Market.It is currently estimated that over 450,000 complete hip replacements are done in the United States each year by the American College of Rheumatology. As per the 2022 American Joint Replacement Registry annual report, between 2012-2021, 37.3% of all submitted cases of arthroplasty were primary total hip arthroplasty surgeries. This extensive use is driving up demand in the target market.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Drivers of the Artificial Hip Joint Market:      

• Growing Geriatric Population across the world and rising life expectancy:

As global populations are getting older there's a higher chance that they will experience health issues such as bone tissue damage that require surgery involving the complete or partial replacement of bone tissue especially in knees and hip region. As people age, their bones and joints tend to wear down, which can lead to pain, stiffness, and difficulty moving.

Older people are consistently at a higher risk of chronic disease, muscular degeneration and frequent hip joint disorders such as osteoarthritis. Hip replacement surgery is a common treatment for these conditions. Hence the need for advanced biocompatible materials and infection resistant artificial hip joint devices that improve mobility as well as the quality of life for elderly patients is rapidly rising. People are living longer, and they are also more active later in life. This means that they are demanding more durable and effective hip replacements that can allow them to maintain an active lifestyle. An increase in global geriatric population is therefore a direct driver for the expansion of the Artificial Hip Joint Market.

Approximately 2,550,532 authentic primary and revision hip and knee arthroplasty cases submitted between 2012 and 2021 are included in the 2022 American Joint Replacement Report (AJRR) annual report. Primary total knee arthroplasty (TKA) procedures accounted for 53.8% of submitted cases, whereas primary total hip arthroplasty (THA) procedures accounted for 37.3% of all submitted cases. In terms of gender, 41.1% of procedures involved male patients, while 58.5% involved female patients.

• Increasing prevalence of hip arthritis and osteoporosis:

Hip arthritis is a condition that causes the cartilage in the hip joint to wear down, which can lead to pain, stiffness, and difficulty moving. Osteoporosis is a condition that weakens the bones, making them more likely to fracture. These conditions are very common in the elderly population due to a lifetime of wear and tear and tissue damage.

With increasing age, the human body’s inherent tissue repair mechanism slows down whereas wear and tear continues to increase ultimately leading to arthritis and osteoporosis. Both of these conditions can lead to hip replacement surgery, and their prevalence is increasing worldwide. This is due to a number of factors, including obesity, inactivity, and poor diet.

• Technological Advancements: 

There have been significant advancements in artificial hip joint technology in recent years. These advancements have led to the development of implants that are more durable, less invasive, and have a longer lifespan. This has made hip replacement surgery a more attractive option for patients, and it is expected to continue to drive the growth of the focussed market. Minimally invasive surgery techniques are becoming increasingly popular for hip replacement surgery. These techniques offer several benefits, such as shorter hospital stays, faster recovery times, and less pain. Robotics and 3D printing are being used to develop more precise and personalized hip implants. This is expected to further improve patient outcomes and drive artificial hip joint market growth.

Restrains:

• High cost of implants and surgery: The cost of artificial hip implants and surgery can be very high, which can be a major barrier for patients, especially in developing countries.
• Risk of complications: There is a risk of complications associated with artificial hip surgery, such as infection, loosening of the implant, and nerve damage. These complications can be very serious and can require additional surgery.
• Limited lifespan of implants: While artificial hip implants can last for many years, they will eventually need to be replaced. This can be a major inconvenience for patients and can also add to the overall cost of treatment.
• Stringent regulatory guidelines: The regulatory requirements for artificial hip implants are very stringent, which can make it difficult for new companies to enter the market and for existing companies to develop new products.

Key Opportunities in Artificial Hip Joint Market:

• Personalization: The artificial hip joint market is moving towards more personalized hip replacements, which are tailored to the individual needs of each patient. This is being driven by advances in 3D printing and other technologies that allow for the creation of custom-made implants.
• Remote monitoring: The use of remote monitoring technology is increasing in the healthcare industry, especially when applied to artificial hip joints. Remote monitoring allows doctors to track the performance of the implant and the health of the patient.
• Increased focus on patient outcomes: There is a growing focus on patient outcomes in healthcare, and this is leading to a demand for artificial hip joints that provide better long-term results. Manufacturers are developing new implants and surgical techniques that are designed to improve patient satisfaction and reduce the risk of complications.

Artificial Hip Joint Market is segmented based on based on by Type, by Application and Region.

Type Insight

• Metal-on-Metal- Their market share is estimated to be around 5% globally. There has been a decline in their popularity in recent years due to growing concerns about release of metal ions and availability of alternative options.
• Metal-on-Polyethylene- This segment currently has the largest market share of around 60% globally. Relatively low cost, good track record of long-term safety and efficacy, and suitability for a wide range of patients are driving factors of its huge global popularity
• Ceramic-on-Metal- This segment is a niche market, with a share of around 5% globally. Their use has declined due to concerns about metal wear and potential squeaking noises.
• Ceramic-on-Polyethylene- This segment’s market share is estimated to be around 20% globally and it is the second largest segment. Its advantages include very low wear rates, good track record of long-term safety and efficacy, and suitable for a wide range of patients, especially younger, more active individuals.
• Ceramic-on-Ceramic- This segment is the fastest-growing segment of the artificial hip joint market, with a share of around 10% globally. Their popularity is due to their excellent wear resistance and potential for long-term durability.

End User Insights

• Hospitals- This segment held the largest market share in 2022, and is expected to maintain its lead throughout the forecast period. Rapid adoption of robotic-assisted surgery for hip replacements, which is associated with better outcomes and shorter hospital stays is a major growth factor for this segment.
• Orthopaedic Clinics- This segment is expected to register the fastest growth in the artificial hip joint market during the forecast period due to rising number of orthopedic surgeons and increasing preference for outpatient settings for hip replacement surgeries
• Ambulatory Surgical Centres- Currently this segment is the second largest in the artificial hip joint market and is expected to witness significant growth in the forecast period as they offer lower costs and shorter wait times for hip replacement surgeries.
• Others- This segment includes nursing homes, long-term care facilities, and home care settings. The growth of this segment is expected to be slow, due to the limited number of hip replacement surgeries performed in these settings.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

 Artificial Hip Joint Market Regional Insights:

On region the Artificial Hip Joint Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America market held the largest market shares of the Artificial Hip Joint Market in 2022 and is estimated to witness a significantly high revenue share over the forecast period. This is due to the growing number of osteoarthritis cases and age related damage leading to hip transplant cases. Technological advancement of hip replacements such as robotic surgery and 3D printing in healthcare is another major growth driver.
• Asia Pacific market is estimated to witness fastest revenue share of the target market due to rapidly growing geriatric population fuelled by the rising cases of arthritis and degenerated bone tissues which need diagnosis and treatment for wear and tear damage. Increasing investment in healthcare research will drive demand for hip joint replacements in this region.
• Europe has developed economies and well-established public healthcare measures; hence it maintains the second largest share of the Artificial Hip Joint Market. Demand for technologically advanced treatment procedures and patient oriented care will promote market expansion in coming years.
• Latin America has smaller market shares but offers significant potential for future growth due to expanding economies and investment in health care. Countries with large geriatric population have scope of holding substantial sections of the target market in the forecast period due to their recent investments in technical advancement of equipment and demand for quality care.
• Middle East & Africa: The Artificial Hip Joint Market in this region is expected to witness significant growth in the coming years, driven by several factors such as the rapid advancement in 3D printing and biomaterial technology and increase in osteoporosis.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Artificial Hip Joint Market report based on By Type, By End User and Region:

 Artificial Hip Joint Market, By Type:

• Metal-on-Metal
• Metal-on-Polyethylene
• Ceramic-on-Metal
• Ceramic-on-Polyethylene
• Ceramic-on-Ceramic

Artificial Hip Joint Market, By End User:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Others

Artificial Hip Joint Market, By Region:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Russia
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• Israel
• South Africa
• Rest of Middle East & Africa

The key players operating the Artificial Hip Joint Market includes, Zimmer Biomet Holdings, Johnson & Johnson services, Inc., Stryker Corporation, Smith & Nephew Healthcare Pvt Ltd., MicroPort Scientific Corporation, Exactech, Inc., DJO Global, Inc., and B. Braun Melsungen AG. and Others.

Recent Development:

• In February 2023, Exactech and JointMedica collaborated to develop the Polymotion Hip Resurfacing System which was granted Breakthrough Device Designation by the FDA in 2022. This system offers the benefits of hip resurfacing (bone preservation) without the metal-on-metal articulation concerns as it utilizes a metal-on-polyethylene articulation, aiming for improved wear resistance and longevity.
• In 2022, Stryker launched the Insignia® Hip Stem, designed for muscle-sparing approaches in total hip and hemi arthroplasty procedures. It focuses on optimizing patient fit and simplifying implantation for surgeons.

• Medacta International*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Zimmer Biomet Holdings
• Johnson & Johnson services, Inc.
• Stryker Corporation
• Smith & Nephew Healthcare Pvt Ltd.
• MicroPort Scientific Corporation
• Exactech, Inc.
• DJO Global, Inc.
• B. Braun Melsungen AG.
• GRUPPO BIOIMPIANTI s.r.l

“*” marked represents similar segmentation in other categories in the respective section.